| George H. Poste Born: c. 1944
Gender: Male
Race or Ethnicity: White
Occupation: Biologist, Business Nationality: England
Executive summary: Health Technology Networks Medical School: DVM, Bristol University
Medical School: PhD Virology, Bristol University
Professor: Research Professor, University of Pennsylvania
Fellow: Pembroke College, Cambridge University
Fellow: University College London
Administrator: Director, Arizona Biodesign Institute, Arizona State University
Health Technology Networks CEO (1999-)
SmithKline Beecham Chief Science & Technology Officer and President of R&D (1992-99)
Member of the Board of AdvancePCS (2002-)
Member of the Board of Anacor Pharmaceuticals
Member of the Board of Caremark Rx (2004-?)
Member of the Board of Caris Diagnostics (2004-?)
Member of the Board of diaDexus (as Chairman 1997-2004)
Member of the Board of Exelixis, Inc.
Member of the Board of Illumina
Member of the Board of Maxygen
Member of the Board of Monsanto (2003-)
Member of the Board of Orchid Cellmark, Inc.
Member of the Board of SmithKline Beecham (1992-99)
Member of the Board of Structural GenomiX (2000-04)
US Defense Department Defense Science Board
Academy of Medical Sciences (UK) Fellow
Council on Foreign Relations
Hoover Institution Fellow
Institute of Medicine Forum on Microbial Threats
Molecular Profiling Institute Board of Directors
National Academy of Sciences Working Group on Biological Weapons
Royal College of Pathologists
Royal Society
Financial Times Columnist
Cancer and Metastasis Reviews Co-Founder
Advanced Drug Delivery Reviews Co-Founder
Nature BioTechnology Editorial Board
Commander of the British Empire
Requires Flash 7+ and Javascript.
Do you know something we don't?
Submit a correction or make a comment about this profile
Copyright ©2019 Soylent Communications
| 
